Loading clinical trials...
Loading clinical trials...
Comparing the Efficacy and Safety of Conventional Therapy With Conventional Therapy Combined Esketamine in the Treatment of Fibromyalgia: A Multicenter Clinical Study
Conditions
Interventions
Pregabalin and venlafaxine concomitant therapy
Esketamine plus pregabalin and venlafaxine concomitant therapy
Locations
1
China
Beijing Tiantan Hospital, Beijing, Beijing 100070
Beijing, China
Start Date
September 15, 2025
Primary Completion Date
June 30, 2027
Completion Date
August 31, 2027
Last Updated
January 27, 2026
NCT07358754
NCT05901259
NCT03759522
NCT07398417
NCT07186751
NCT07247968
Lead Sponsor
Beijing Tiantan Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions